位置:首页 > 蛋白库 > COEA1_HUMAN
COEA1_HUMAN
ID   COEA1_HUMAN             Reviewed;        1796 AA.
AC   Q05707; B2RU07; O00260; O00261; O00262; Q05708; Q5XJ18; Q96C67; Q9UDF6;
DT   01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   06-FEB-2007, sequence version 3.
DT   03-AUG-2022, entry version 177.
DE   RecName: Full=Collagen alpha-1(XIV) chain;
DE   AltName: Full=Undulin;
DE   Flags: Precursor;
GN   Name=COL14A1 {ECO:0000312|HGNC:HGNC:2191}; Synonyms=UND;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAH83495.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT LEU-1342.
RC   TISSUE=Brain, Muscle {ECO:0000312|EMBL:AAH14640.1}, and
RC   PNS {ECO:0000312|EMBL:AAH83495.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:CAA72402.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-165, NUCLEOTIDE SEQUENCE [MRNA] OF
RP   1026-1796 (ISOFORM 1), AND NUCLEOTIDE SEQUENCE [MRNA] OF 1760-1796 (ISOFORM
RP   2).
RX   PubMed=9427527; DOI=10.1016/s0167-4781(97)00131-0;
RA   Bauer M., Dieterich W., Ehnis T., Schuppan D.;
RT   "Complete primary structure of human collagen type XIV (undulin).";
RL   Biochim. Biophys. Acta 1354:183-188(1997).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:AAA36794.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 149-582 (ISOFORM 3), AND NUCLEOTIDE SEQUENCE
RP   [MRNA] OF 188-1030 (ISOFORM 1).
RX   PubMed=1716629; DOI=10.1016/s0021-9258(19)47377-8;
RA   Just M., Herbst H., Hummel M., Duerkop H., Tripier D., Stein H.,
RA   Schuppan D.;
RT   "Undulin is a novel member of the fibronectin-tenascin family of
RT   extracellular matrix glycoproteins.";
RL   J. Biol. Chem. 266:17326-17332(1991).
RN   [5]
RP   PROTEIN SEQUENCE OF 1459-1635 AND 1640-1767, HYDROXYLATION AT PRO-1467;
RP   PRO-1470; LYS-1476; PRO-1482; LYS-1485; PRO-1497; PRO-1503; PRO-1517;
RP   PRO-1520; LYS-1523; LYS-1526; PRO-1532; PRO-1538; PRO-1544; PRO-1550;
RP   PRO-1556; PRO-1565; PRO-1568; PRO-1574; PRO-1577; PRO-1580; PRO-1595;
RP   PRO-1598; LYS-1601; PRO-1643; PRO-1656; PRO-1659; PRO-1662; PRO-1665;
RP   PRO-1668; PRO-1674; PRO-1677; PRO-1680; PRO-1686; PRO-1689; LYS-1698;
RP   LYS-1701; PRO-1704; PRO-1715; PRO-1726; PRO-1729; PRO-1732; PRO-1735;
RP   PRO-1741; PRO-1747 AND PRO-1756, AND GLYCOSYLATION AT LYS-1476; LYS-1485;
RP   LYS-1523; LYS-1526; LYS-1601; LYS-1698 AND LYS-1701.
RC   TISSUE=Placenta;
RX   PubMed=7827751; DOI=10.1016/0945-053x(94)90194-5;
RA   Brown J.C., Golbik R., Mann K., Timpl R.;
RT   "Structure and stability of the triple-helical domains of human collagen
RT   XIV.";
RL   Matrix Biol. 14:287-295(1994).
RN   [6] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=2187872; DOI=10.1016/s0021-9258(19)38962-8;
RA   Schuppan D., Cantaluppi M., Becker J., Veit A., Bunte T., Troyer D.,
RA   Schuppan F., Schmid M., Ackermann R., Hahn E.;
RT   "Undulin, an extracellular matrix glycoprotein associated with collagen
RT   fibrils.";
RL   J. Biol. Chem. 265:8823-8832(1990).
RN   [7]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-94; ASN-372; ASN-1384 AND
RP   ASN-1388.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Plays an adhesive role by integrating collagen bundles. It is
CC       probably associated with the surface of interstitial collagen fibrils
CC       via COL1. The COL2 domain may then serve as a rigid arm which sticks
CC       out from the fibril and protrudes the large N-terminal globular domain
CC       into the extracellular space, where it might interact with other matrix
CC       molecules or cell surface receptors (By similarity). {ECO:0000250,
CC       ECO:0000269|PubMed:2187872}.
CC   -!- SUBUNIT: Homotrimer. {ECO:0000250|UniProtKB:P32018}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000250|UniProtKB:P32018}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1 {ECO:0000269|PubMed:9427527}; Synonyms=Undulin 1
CC       {ECO:0000303|PubMed:1716629}, Un1 {ECO:0000303|PubMed:1716629};
CC         IsoId=Q05707-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:9427527};
CC         IsoId=Q05707-2; Sequence=VSP_051654;
CC       Name=3 {ECO:0000269|PubMed:1716629}; Synonyms=Undulin 2
CC       {ECO:0000303|PubMed:1716629}, Un2 {ECO:0000303|PubMed:1716629};
CC         IsoId=Q05707-3; Sequence=VSP_051653;
CC   -!- PTM: Lysines at the third position of the tripeptide repeating unit (G-
CC       X-Y) are hydroxylated in all cases and bind carbohydrates.
CC       {ECO:0000250|UniProtKB:P32018}.
CC   -!- PTM: Prolines at the third position of the tripeptide repeating unit
CC       (G-X-Y) are hydroxylated in some or all of the chains.
CC       {ECO:0000250|UniProtKB:P32018}.
CC   -!- PTM: May contain numerous cysteine residues involved in inter- and
CC       intramolecular disulfide bonding. {ECO:0000250|UniProtKB:P32018}.
CC   -!- SIMILARITY: Belongs to the fibril-associated collagens with interrupted
CC       helices (FACIT) family. {ECO:0000255}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA36795.1; Type=Miscellaneous discrepancy; Evidence={ECO:0000305};
CC       Sequence=AAH14640.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC020603; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090735; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC107877; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC014640; AAH14640.1; ALT_FRAME; mRNA.
DR   EMBL; BC083495; AAH83495.1; -; mRNA.
DR   EMBL; BC140893; AAI40894.1; -; mRNA.
DR   EMBL; Y11709; CAA72401.1; -; mRNA.
DR   EMBL; Y11710; CAA72402.1; -; mRNA.
DR   EMBL; Y11711; CAA72403.1; -; mRNA.
DR   EMBL; M64108; AAA36794.1; -; mRNA.
DR   EMBL; M64109; AAA36795.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS34938.1; -. [Q05707-1]
DR   PIR; A40970; A40970.
DR   PIR; B40970; B40970.
DR   PIR; S37749; S37749.
DR   PIR; S46657; S46657.
DR   RefSeq; NP_066933.1; NM_021110.3. [Q05707-1]
DR   RefSeq; XP_005251116.1; XM_005251059.3.
DR   RefSeq; XP_006716714.1; XM_006716651.3. [Q05707-1]
DR   RefSeq; XP_016869298.1; XM_017013809.1. [Q05707-1]
DR   AlphaFoldDB; Q05707; -.
DR   SMR; Q05707; -.
DR   BioGRID; 113219; 82.
DR   ComplexPortal; CPX-1755; Collagen type XIV trimer.
DR   IntAct; Q05707; 34.
DR   STRING; 9606.ENSP00000297848; -.
DR   GlyConnect; 1132; 18 N-Linked glycans (4 sites).
DR   GlyGen; Q05707; 19 sites, 17 N-linked glycans (4 sites), 8 O-linked glycans (7 sites).
DR   iPTMnet; Q05707; -.
DR   PhosphoSitePlus; Q05707; -.
DR   BioMuta; COL14A1; -.
DR   DMDM; 125987815; -.
DR   EPD; Q05707; -.
DR   jPOST; Q05707; -.
DR   MassIVE; Q05707; -.
DR   MaxQB; Q05707; -.
DR   PaxDb; Q05707; -.
DR   PeptideAtlas; Q05707; -.
DR   PRIDE; Q05707; -.
DR   ProteomicsDB; 58350; -. [Q05707-1]
DR   ProteomicsDB; 58351; -. [Q05707-2]
DR   ProteomicsDB; 58352; -. [Q05707-3]
DR   Antibodypedia; 13712; 117 antibodies from 24 providers.
DR   DNASU; 7373; -.
DR   Ensembl; ENST00000297848.8; ENSP00000297848.3; ENSG00000187955.13. [Q05707-1]
DR   Ensembl; ENST00000309791.8; ENSP00000311809.4; ENSG00000187955.13. [Q05707-2]
DR   GeneID; 7373; -.
DR   KEGG; hsa:7373; -.
DR   MANE-Select; ENST00000297848.8; ENSP00000297848.3; NM_021110.4; NP_066933.1.
DR   UCSC; uc003yox.5; human. [Q05707-1]
DR   CTD; 7373; -.
DR   DisGeNET; 7373; -.
DR   GeneCards; COL14A1; -.
DR   HGNC; HGNC:2191; COL14A1.
DR   HPA; ENSG00000187955; Tissue enhanced (cervix).
DR   MalaCards; COL14A1; -.
DR   MIM; 120324; gene.
DR   neXtProt; NX_Q05707; -.
DR   OpenTargets; ENSG00000187955; -.
DR   Orphanet; 79501; Punctate palmoplantar keratoderma type 1.
DR   PharmGKB; PA26707; -.
DR   VEuPathDB; HostDB:ENSG00000187955; -.
DR   eggNOG; KOG3544; Eukaryota.
DR   GeneTree; ENSGT00940000153769; -.
DR   HOGENOM; CLU_002527_2_0_1; -.
DR   InParanoid; Q05707; -.
DR   OMA; RITWDPA; -.
DR   OrthoDB; 67372at2759; -.
DR   PhylomeDB; Q05707; -.
DR   TreeFam; TF329914; -.
DR   PathwayCommons; Q05707; -.
DR   Reactome; R-HSA-1442490; Collagen degradation.
DR   Reactome; R-HSA-1650814; Collagen biosynthesis and modifying enzymes.
DR   Reactome; R-HSA-2022090; Assembly of collagen fibrils and other multimeric structures.
DR   Reactome; R-HSA-8948216; Collagen chain trimerization.
DR   SignaLink; Q05707; -.
DR   SIGNOR; Q05707; -.
DR   BioGRID-ORCS; 7373; 11 hits in 1070 CRISPR screens.
DR   ChiTaRS; COL14A1; human.
DR   GeneWiki; Collagen,_type_XIV,_alpha_1; -.
DR   GenomeRNAi; 7373; -.
DR   Pharos; Q05707; Tbio.
DR   PRO; PR:Q05707; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q05707; protein.
DR   Bgee; ENSG00000187955; Expressed in descending thoracic aorta and 167 other tissues.
DR   ExpressionAtlas; Q05707; baseline and differential.
DR   Genevisible; Q05707; HS.
DR   GO; GO:0005581; C:collagen trimer; NAS:UniProtKB.
DR   GO; GO:0005596; C:collagen type XIV trimer; NAS:UniProtKB.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:BHF-UCL.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0031012; C:extracellular matrix; NAS:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; HDA:BHF-UCL.
DR   GO; GO:0005615; C:extracellular space; HDA:BHF-UCL.
DR   GO; GO:0005614; C:interstitial matrix; IBA:GO_Central.
DR   GO; GO:0005518; F:collagen binding; NAS:UniProtKB.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; NAS:UniProtKB.
DR   GO; GO:0030020; F:extracellular matrix structural constituent conferring tensile strength; ISS:BHF-UCL.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; NAS:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0098609; P:cell-cell adhesion; NAS:UniProtKB.
DR   GO; GO:0030199; P:collagen fibril organization; NAS:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; NAS:UniProtKB.
DR   CDD; cd00063; FN3; 8.
DR   Gene3D; 2.60.40.10; -; 8.
DR   Gene3D; 3.40.50.410; -; 2.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR001791; Laminin_G.
DR   InterPro; IPR002035; VWF_A.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   Pfam; PF01391; Collagen; 4.
DR   Pfam; PF00041; fn3; 8.
DR   Pfam; PF00092; VWA; 2.
DR   SMART; SM00060; FN3; 8.
DR   SMART; SM00210; TSPN; 1.
DR   SMART; SM00327; VWA; 2.
DR   SUPFAM; SSF49265; SSF49265; 5.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   SUPFAM; SSF53300; SSF53300; 2.
DR   PROSITE; PS50853; FN3; 8.
DR   PROSITE; PS50234; VWFA; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Collagen; Direct protein sequencing;
KW   Disulfide bond; Extracellular matrix; Glycoprotein; Hydroxylation;
KW   Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL          1..28
FT                   /evidence="ECO:0000255"
FT   CHAIN           29..1796
FT                   /note="Collagen alpha-1(XIV) chain"
FT                   /id="PRO_0000005785"
FT   DOMAIN          32..122
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          158..330
FT                   /note="VWFA 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00219"
FT   DOMAIN          355..444
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          445..536
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          537..626
FT                   /note="Fibronectin type-III 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          627..715
FT                   /note="Fibronectin type-III 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          737..829
FT                   /note="Fibronectin type-III 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          831..921
FT                   /note="Fibronectin type-III 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          922..1010
FT                   /note="Fibronectin type-III 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1032..1205
FT                   /note="VWFA 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00219"
FT   DOMAIN          1229..1424
FT                   /note="Laminin G-like"
FT   DOMAIN          1462..1510
FT                   /note="Collagen-like 1"
FT   DOMAIN          1514..1570
FT                   /note="Collagen-like 2"
FT   DOMAIN          1571..1609
FT                   /note="Collagen-like 3"
FT   DOMAIN          1653..1705
FT                   /note="Collagen-like 4"
FT   REGION          124..145
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1217..1458
FT                   /note="Nonhelical region (NC4)"
FT   REGION          1459..1610
FT                   /note="Triple-helical region 1 (COL2)"
FT   REGION          1462..1613
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1644..1781
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1654..1779
FT                   /note="Triple-helical region 2 (COL1)"
FT   MOTIF           1607..1609
FT                   /note="Cell attachment site"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        1561..1575
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1658..1675
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1710..1747
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1467
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1470
FT                   /note="4-hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1476
FT                   /note="5-hydroxylysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1482
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1485
FT                   /note="5-hydroxylysine; partial"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1497
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1503
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1517
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1520
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1523
FT                   /note="5-hydroxylysine; partial"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1526
FT                   /note="5-hydroxylysine; partial"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1532
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1538
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1544
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1550
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1556
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1565
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1568
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1574
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1577
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1580
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1595
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1598
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1601
FT                   /note="5-hydroxylysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1643
FT                   /note="4-hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1656
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1659
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1662
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1665
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1668
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1674
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1677
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1680
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1686
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1689
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1698
FT                   /note="5-hydroxylysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1701
FT                   /note="5-hydroxylysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1704
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1715
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1726
FT                   /note="4-hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1729
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1732
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1735
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1741
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1747
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   MOD_RES         1756
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   CARBOHYD        94
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CARBOHYD        137
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        372
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CARBOHYD        1384
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CARBOHYD        1388
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CARBOHYD        1476
FT                   /note="O-linked (Gal...) hydroxylysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   CARBOHYD        1485
FT                   /note="O-linked (Gal...) hydroxylysine; partial"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   CARBOHYD        1523
FT                   /note="O-linked (Gal...) hydroxylysine; partial"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   CARBOHYD        1526
FT                   /note="O-linked (Gal...) hydroxylysine; partial"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   CARBOHYD        1601
FT                   /note="O-linked (Gal...) hydroxylysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   CARBOHYD        1698
FT                   /note="O-linked (Gal...) hydroxylysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   CARBOHYD        1701
FT                   /note="O-linked (Gal...) hydroxylysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:7827751"
FT   VAR_SEQ         197..291
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:1716629"
FT                   /id="VSP_051653"
FT   VAR_SEQ         1771..1796
FT                   /note="APHPDQPEFTPVQDELEAMELWGPGV -> DLIPYNDYQH (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:9427527"
FT                   /id="VSP_051654"
FT   VARIANT         563
FT                   /note="N -> H (in dbSNP:rs4870723)"
FT                   /id="VAR_048772"
FT   VARIANT         636
FT                   /note="T -> A (in dbSNP:rs56815167)"
FT                   /id="VAR_061113"
FT   VARIANT         855
FT                   /note="P -> L (in dbSNP:rs2305606)"
FT                   /id="VAR_048773"
FT   VARIANT         922
FT                   /note="V -> I (in dbSNP:rs11774228)"
FT                   /id="VAR_048774"
FT   VARIANT         1342
FT                   /note="V -> L (in dbSNP:rs17833992)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_048775"
FT   CONFLICT        616
FT                   /note="T -> I (in Ref. 2; AAA36794)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1025
FT                   /note="V -> G (in Ref. 2; AAA36794)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1796 AA;  193515 MW;  30A72F6E2CC07F70 CRC64;
     MKIFQRKMRY WLLPPFLAIV YFCTIVQGQV APPTRLRYNV ISHDSIQISW KAPRGKFGGY
     KLLVTPTSGG KTNQLNLQNT ATKAIIQGLM PDQNYTVQII AYNKDKESKP AQGQFRIKDL
     EKRKDPKPRV KVVDRGNGSR PSSPEEVKFV CQTPAIADIV ILVDGSWSIG RFNFRLVRHF
     LENLVTAFDV GSEKTRIGLA QYSGDPRIEW HLNAFSTKDE VIEAVRNLPY KGGNTLTGLA
     LNYIFENSFK PEAGSRTGVS KIGILITDGK SQDDIIPPSR NLRESGVELF AIGVKNADVN
     ELQEIASEPD STHVYNVAEF DLMHTVVESL TRTLCSRVEE QDREIKASAH AITGPPTELI
     TSEVTARSFM VNWTHAPGNV EKYRVVYYPT RGGKPDEVVV DGTVSSTVLK NLMSLTEYQI
     AVFAIYAHTA SEGLRGTETT LALPMASDLL LYDVTENSMR VKWDAVPGAS GYLILYAPLT
     EGLAGDEKEM KIGETHTDIE LSGLLPNTEY TVTVYAMFGE EASDPVTGQE TTLALSPPRN
     LRISNVGSNS ARLTWDPTSR QINGYRIVYN NADGTEINEV EVDPITTFPL KGLTPLTEYT
     IAIFSIYDEG QSEPLTGVFT TEEVPAQQYL EIDEVTTDSF RVTWHPLSAD EGLHKLMWIP
     VYGGKTEEVV LKEEQDSHVI EGLEPGTEYE VSLLAVLDDG SESEVVTAVG TTLDSFWTEP
     ATTIVPTTSV TSVFQTGIRN LVVGDETTSS LRVKWDISDS DVQQFRVTYM TAQGDPEEEV
     IGTVMVPGSQ NNLLLKPLLP DTEYKVTVTP IYTDGEGVSV SAPGKTLPSS GPQNLRVSEE
     WYNRLRITWD PPSSPVKGYR IVYKPVSVPG PTLETFVGAD INTILITNLL SGMDYNVKIF
     ASQASGFSDA LTGMVKTLFL GVTNLQAKHV EMTSLCAHWQ VHRHATAYRV VIESLQDRQK
     QESTVGGGTT RHCFYGLQPD SEYKISVYTK LQEIEGPSVS IMEKTQSLPT RPPTFPPTIP
     PAKEVCKAAK ADLVFMVDGS WSIGDENFNK IISFLYSTVG ALNKIGTDGT QVAMVQFTDD
     PRTEFKLNAY KTKETLLDAI KHISYKGGNT KTGKAIKYVR DTLFTAESGT RRGIPKVIVV
     ITDGRSQDDV NKISREMQLD GYSIFAIGVA DADYSELVSI GSKPSARHVF FVDDFDAFKK
     IEDELITFVC ETASATCPVV HKDGIDLAGF KMMEMFGLVE KDFSSVEGVS MEPGTFNVFP
     CYQLHKDALV SQPTRYLHPE GLPSDYTISF LFRILPDTPQ EPFALWEILN KNSDPLVGVI
     LDNGGKTLTY FNYDQSGDFQ TVTFEGPEIR KIFYGSFHKL HIVVSETLVK VVIDCKQVGE
     KAMNASANIT SDGVEVLGKM VRSRGPGGNS APFQLQMFDI VCSTSWANTD KCCELPGLRD
     DESCPDLPHS CSCSETNEVA LGPAGPPGGP GLRGPKGQQG EPGPKGPDGP RGEIGLPGPQ
     GPPGPQGPSG LSIQGMPGMP GEKGEKGDTG LPGPQGIPGG VGSPGRDGSP GQRGLPGKDG
     SSGPPGPPGP IGIPGTPGVP GITGSMGPQG ALGPPGVPGA KGERGERGDL QSQAMVRSVA
     RQVCEQLIQS HMARYTAILN QIPSHSSSIR TVQGPPGEPG RPGSPGAPGE QGPPGTPGFP
     GNAGVPGTPG ERGLTGIKGE KGNPGVGTQG PRGPPGPAGP SGESRPGSPG PPGSPGPRGP
     PGHLGVPGPQ GPSGQPGYCD PSSCSAYGVR APHPDQPEFT PVQDELEAME LWGPGV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024